Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,572 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02430298 | Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients | completed | Phase 2 | 39 | Khon Kaen UniversityOTHER | 1 | Feb 24, 2016 | clinicaltrials |
| NCT01695122 | Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 14 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT01333085 | Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery(CAPRA) | completed | Phase 1 / Phase 2 | 49 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT00006341 | Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer | completed | Phase 2 | 46 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT00454142 | Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer | completed | Phase 2 | 33 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2015 | clinicaltrials |
| NCT01183065 | Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) | completed | Phase 2 | 13 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00005087 | Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer | completed | Phase 2 | 105 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT00011999 | Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer | completed | Phase 2 | 70 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT02061631 | Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck(DECIDE) | completed | Phase 2 | 35 | SanofiINDUSTRY | 1 | Oct 8, 2015 | clinicaltrials |
| NCT01173289 | Study of External Beam Radiotherapy to Thyroid Carcinoma | completed | Phase 2 | 62 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01733797 | Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients | completed | Phase 2 | 71 | Brynn ChappellOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT01616849 | Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma | completed | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 1 | Sep 22, 2015 | clinicaltrials |
| NCT01678105 | A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands(DOVE) | completed | Phase 2 | 21 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Sep 17, 2015 | clinicaltrials |
| NCT00337129 | S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Aug 25, 2015 | clinicaltrials |
| NCT01192204 | Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention | completed | Phase 1 / Phase 2 | 41 | Ohio State UniversityOTHER | 1 | Aug 14, 2015 | clinicaltrials |
| NCT00565448 | Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents | completed | Phase 2 | 75 | SanofiINDUSTRY | 14 | Jul 30, 2015 | clinicaltrials |
| NCT00886132 | A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands | completed | Phase 2 | 14 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01116843 | Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment | completed | Phase 1 / Phase 2 | 13 | University Health Network, TorontoOTHER | 1 | Jul 10, 2015 | clinicaltrials |
| NCT00387127 | Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer | completed | Phase 2 | 67 | GlaxoSmithKlineINDUSTRY | 9 | Jun 25, 2015 | clinicaltrials |
| NCT00281840 | Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT00508664 | Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)(DeLOS II) | completed | Phase 2 | 180 | ClinAssessOTHER | 2 | Jun 2, 2015 | clinicaltrials |
| NCT02460471 | Palliative Radiotherapy Protocol in Head and Neck Cancer | completed | Phase 2 | 32 | Maisonneuve-Rosemont HospitalOTHER | 1 | Jun 2, 2015 | clinicaltrials |
| NCT00570232 | UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer(UAB0718) | completed | Phase 2 | 31 | University of Alabama at BirminghamOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT00199160 | Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 60 | Jules Bordet InstituteOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT01152840 | Study of RAD001 in Adenoid Cystic Carcinoma(ACCRAD001) | completed | Phase 2 | 33 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00827164 | Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer | completed | Phase 2 | 29 | University of Alabama at BirminghamOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00458978 | Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer | completed | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00713219 | Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer | completed | Phase 2 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 23, 2015 | clinicaltrials |
| NCT00114283 | Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01790204 | A Study of the Effects of PEITC on Oral Cells With Mutant p53 | completed | Phase 1 / Phase 2 | 55 | Georgetown UniversityOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT01596933 | Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy(NUTRIOM) | completed | Phase 2 / Phase 3 | 91 | General Hospital GroeningeOTHER | 1 | Mar 10, 2015 | clinicaltrials |
| NCT01032928 | Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer(RSPT) | completed | Phase 2 | 30 | US Department of Veterans AffairsFED | 1 | Jan 1, 2015 | clinicaltrials |
| NCT00330382 | Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia | completed | Phase 2 | 325 | National Cancer Institute (NCI)NIH | 1 | Dec 19, 2014 | clinicaltrials |
| NCT01283334 | A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer | completed | Phase 1 / Phase 2 | 20 | Emory UniversityOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT01164176 | Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer | completed | Phase 2 | 40 | Yonsei UniversityOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01964144 | An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer | completed | Phase 2 | 40 | Yonsei UniversityOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00002932 | Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck | completed | Phase 2 | 60 | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 21, 2014 | clinicaltrials |
| NCT00697905 | Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma | completed | Phase 2 | 18 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Nov 21, 2014 | clinicaltrials |
| NCT01417143 | Dovitinib in Adenoid Cystic Carcinoma | completed | Phase 2 | 33 | Seoul National University HospitalOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01465308 | The Effect of Honey on Xerostomia and Oral Mucositis(AC-H) | completed | Phase 2 | 72 | Cyprus University of TechnologyOTHER | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00507767 | Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Oct 1, 2014 | clinicaltrials |
| NCT01797900 | The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT | completed | Phase 2 | 130 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT01903018 | A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00 | completed | Phase 2 | 73 | Piramal Enterprises LimitedINDUSTRY | 1 | Sep 4, 2014 | clinicaltrials |
| NCT00134043 | Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | Aug 11, 2014 | clinicaltrials |
| NCT00113334 | Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer | completed | Phase 1 / Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2014 | clinicaltrials |
| NCT00049140 | EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer | completed | Phase 2 | 8 | David M. Brizel, MDOTHER | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00387335 | Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00002774 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 63 | Stanford UniversityOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00141765 | Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | completed | Phase 2 | 25 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 20, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Feb 24, 2016source: clinicaltrials